Michael V. Gormally, MD, PhD
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Breast cancers and conditions
- Colon cancer
- Pancreatic cancer
My Specialties
- Immunotherapy
- Cellular therapy
- Cancer vaccines
Get to Know Me
I am a medical oncologist and physician-scientist with a focus on cellular therapies for solid tumors. As a member of the Cellular Therapy Service at Memorial Sloan Kettering Cancer Center (MSK), I create new types of cancer treatments that use the body’s own immune system—like specially modified T cells—to help patients whose cancer doesn’t improve with standard treatments.
I care for people with advanced cancers who are candidates for clinical trials involving engineered immune cells. These trials are often therapies developed right here at MSK. My goal is to offer my patients not only access to cutting-edge therapies, but also the information and guidance needed to make confident, informed decisions about their care. Many of my patients are referred to me because they have limited standard treatment options, and I work closely with them to ensure they understand the science and strategy behind each approach.
In my research, I focus on discovering and developing new classes of personalized cell therapies. Several of our group’s discoveries are currently being evaluated in early phase clinical trials, a bench-to-bedside path that I hope to replicate for many targets in the future. I also study why some cancers resist immune-based treatments—like when they stop showing signals (such as HLA) that help the immune system recognize them—and how we can design better cell therapies to beat that resistance.
I was drawn to oncology through both personal experience and scientific curiosity. Cancer is a disease that tests the boundaries of medicine, and I believe the future of cancer care lies in translating innovation into real-world options for patients. When I’m not in the clinic or lab, I’m often out in nature. I’ve guided mountaineering expeditions in the Bolivian Andes and Rockies, once swam the English Channel, and enjoy running the NYC Marathon annually as a part of MSK’s Fred’s Team. I aim to bring that same determination and focus when caring for all of my patients.
A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.
- Assistant Attending Physician
Conditions I Treat
- Breast cancers and conditions
- Colon cancer
- Pancreatic cancer
My Specialties
- Immunotherapy
- Cellular therapy
- Cancer vaccines
- Clinical trials
Education
- BA, Pomona College
- MPhil, University of Cambridge
- PhD, University of Cambridge
- MD, Yale School of Medicine
Residencies
- Internal Medicine
Fellowships
- Hematology and Oncology, Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
Awards and Honors
- Damon Runyon Dammerman Fellowship Award (2024-2028)
- Louis V. Gerstner, Jr. Physician Scholar Fellowship Award (2024-2027)
- Arnoldus Goudsmit Young Investigator Award, American Society of Clinical Oncology (2024-2025)
- Innovation Award for Novel Solutions in Biomedicine, International Biomedical Research Alliance (2015)
- Churchill Fellowship, Winston Churchill Memorial Trust (2011-2012)
- Stauffer and Brackett Prizes, Pomona College (2011)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
State Government
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Goldlust IS, Gormally MV, Teichholtz S, Turriff AE, Harding JJ, Bianchi DW. Prenatal Cell-Free DNA Sequencing and Intrahepatic Cholangiocarcinoma.” JCO Precision Oncology. 2025 Jun;9:e2500186.
Gormally MV, Chen MF, Noronha AM, Panageas K, Reynolds M, Kohlasch K, Novak B, Kee-Velez T, Clarke N, Eubank M, Chu C, Wilhelm C, Blouin A, Kyi C, Friedman C, Rudin CM, Kris MG, Shah R, Aggen D, D’Angelo S, Shoushtari AN, Berger MF, Bandlamudi C, Klebanoff CA, Drilon A, Schoenfeld AJ, Donoghue MTA. Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies.” JAMA Oncology. 2025;11(1):74-76.
Briggs N, Gormally MV, Li F, Browning SL, Treggiari MM, Morrison A, Laurent-Rolle M, Deng Y, Hendrickson JE, Tormey CA, Mahalia S, Desruisseaux MS. Early vs late convalescent plasma inpatients with COVID-19: A propensity score-matched cohort study. PLoS One. 2021;16(7).
Gormally MV, Dexheimer TS, Marsico G, et al. Suppression of the FOXM1 transcriptional programme via novel small molecule inhibition. Nature Communications. 2014;5:5165.
Visit PubMed for a full listing of Dr. Gormally’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Michael V. Gormally discloses the following relationships and financial interests:
-
Affini-T Therapeutics
Intellectual Property Rights
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].